120 related articles for article (PubMed ID: 36563909)
1. Endocrinopathy After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy.
Merchant TE; Wu S; Onar-Thomas A; Delaney A; Gajjar A
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):560-568. PubMed ID: 36563909
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadism After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy.
Merchant TE; Wu S; Onar-Thomas A; Gajjar A; Delaney A
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):569-578. PubMed ID: 36641041
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
Aldrich KD; Horne VE; Bielamowicz K; Sonabend RY; Scheurer ME; Paulino AC; Mahajan A; Chintagumpala M; Okcu MF; Brown AL
J Neurooncol; 2021 Oct; 155(1):93-100. PubMed ID: 34596831
[TBL] [Abstract][Full Text] [Related]
4. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
5. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
6. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
Laughton SJ; Merchant TE; Sklar CA; Kun LE; Fouladi M; Broniscer A; Morris EB; Sanders RP; Krasin MJ; Shelso J; Xiong Z; Wallace D; Gajjar A
J Clin Oncol; 2008 Mar; 26(7):1112-8. PubMed ID: 18309946
[TBL] [Abstract][Full Text] [Related]
7. Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy.
Xu W; Janss A; Packer RJ; Phillips P; Goldwein J; Moshang T
Neuro Oncol; 2004 Apr; 6(2):113-8. PubMed ID: 15134625
[TBL] [Abstract][Full Text] [Related]
8. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
Paulino AC
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma.
Bielamowicz K; Okcu MF; Sonabend R; Paulino AC; Hilsenbeck SG; Dreyer Z; Suzawa H; Bryant R; Adesina A; Dauser R; Mahajan A; Chintagumpala M
Pediatr Hematol Oncol; 2018 May; 35(4):257-267. PubMed ID: 30537887
[TBL] [Abstract][Full Text] [Related]
10. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy.
Ricardi U; Corrias A; Einaudi S; Genitori L; Sandri A; di Montezemolo LC; Besenzon L; Madon E; Urgesi A
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1287-94. PubMed ID: 11483340
[TBL] [Abstract][Full Text] [Related]
11. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.
Eaton BR; Esiashvili N; Kim S; Patterson B; Weyman EA; Thornton LT; Mazewski C; MacDonald TJ; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Neuro Oncol; 2016 Jun; 18(6):881-7. PubMed ID: 26688075
[TBL] [Abstract][Full Text] [Related]
12. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
[TBL] [Abstract][Full Text] [Related]
13. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function.
Oberfield SE; Allen JC; Pollack J; New MI; Levine LS
J Pediatr; 1986 Feb; 108(2):219-23. PubMed ID: 3944706
[TBL] [Abstract][Full Text] [Related]
14. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma.
Heikens J; Michiels EM; Behrendt H; Endert E; Bakker PJ; Fliers E
Eur J Cancer; 1998 Sep; 34(10):1592-7. PubMed ID: 9893634
[TBL] [Abstract][Full Text] [Related]
15. Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols.
Corrias A; Einaudi S; Ricardi U; Sandri A; Besenzon L; Altare F; Artesani L; Genitori L; Andreo M; De Sanctis C
J Endocrinol Invest; 2001 Jun; 24(6):387-92. PubMed ID: 11434661
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
17. Effects of puberty on bone age maturation in a girl after medulloblastoma therapy.
Marx M; Schoof E; Grabenbauer GG; Beck JD; Doerr HG
J Pediatr Adolesc Gynecol; 1999 May; 12(2):62-6. PubMed ID: 10326189
[TBL] [Abstract][Full Text] [Related]
18. Endocrine sequelae beyond 10 years in survivors of medulloblastoma.
Uday S; Murray RD; Picton S; Chumas P; Raju M; Chandwani M; Alvi S
Clin Endocrinol (Oxf); 2015 Nov; 83(5):663-70. PubMed ID: 25952583
[TBL] [Abstract][Full Text] [Related]
19. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M;
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
